Overview

Our
Company

We are more than a radioisotope supplier. We are solving the challenges facing U.S. radioisotope customers and constantly evolving to meet changing needs.

IN OUR EFFORTS TO DELIVER
CREATIVE SOLUTIONS, WE
CLEARLY DEFINE

WHO
WE ARE

We are innovators who revolutionized the reliable production of Mo-99. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics and therapeutics that will serve the next generation of medical advances for patients.

THE RADIOPHARMACEUTICAL MARKET
DEMANDS CREATIVE, ORIGINAL
THINKING, LIKE THAT PIONEERED BY OUR

LEADERSHIP
TEAM

Our executive team brings proven experience and expertise in developing and commercializing innovative nuclear medicine products and technologies.

LATEST NEWS, PRESS RELEASES & EVENTS


Press Releases - Aug 29, 2023
NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

Press Releases - Aug 28, 2023
First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

News - Aug 24, 2023
Part of a cancer cure? Wisconsin doctor discusses growth of nuclear medicine
Oct 23, 2023 - Oct 26, 2023
Symposium
21st Symposium on Separation Science and Technology for Energy Applications (SS&T 2023)
Sponsoring, Attending